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Abstract 
6-Fluoropyridoxol was evaluated as an intracellular pH indicator. This molecule exhibits exceptional sensitivity to changes in pH (- IO ppm acid/base 
shift) and a pK, -8.2 appropriate for physiological investigations. Using 19F NMR spectroscopy we determined both intra- and extracellular pH in 
whole blood and confirmed the measurements using traditional techniques: ion-electrodes and “P NMR spectroscopy. 
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1. Introduction 
Intracellular and interstitial pH are thought to play 
significant roles in cellular regulation and tissue develop- 
ment. It has been shown that tumor pH influences cell 
thermosensitivity, radiation sensitivity and proliferation 
[I]. In addition, pH is reported to influence the efficacy 
of certain chemotherapeutic drugs for cancer therapy 
[ 1,2]. Thus, an accurate non-invasive assessment of tissue 
pH may provide a prediction of therapeutic success. pH 
measurement by a variety of techniques including micro- 
electrodes, fluorescence spectrophotometry, partitioning 
of radio-labelled weak acids and NMR has been exten- 
sively reviewed [3,4,5]. NMR offers several potential ad- 
vantages: continuous non-destructive monitoring of pH 
in vivo; spatial resolution and simultaneous determina- 
tion of pH in several compartments [4,5]. NMR has been 
used to monitor titratable groups of endogenous meta- 
bolites on the basis of chemical shift with respect to 
changing pH; in particular 3’P NMR of inorganic phos- 
phate (Pi) [5,6] or phosphomonoesters [7] or ‘H NMR of 
carnosine [8] or histidine [9]. pH measurement using en- 
dogenous metabolites is not always successful owing to 
crowded spectra, broad lines or low metabolite concen- 
tration. Thus, various infusable agents have been devel- 
oped [lO,l 11. In particular “F-1abelled molecules, which 
exploit the high visibility of fluorine, the great sensitivity 
of 19F to the micro-environmental millieu and the lack 
of background signal [ 10,121. Widespread application of 
such molecules has been hindered by low response to 
changes in pH [lo] or pK, far from the physiological 
range [13]. The vitamin B6 analogue 6-FPOL (Fig. 1) has 
previously been reported to have a pK, in the physiolog- 
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ical range and large chemical shift response [141. We have 
now investigated the feasibility of using 6-FPOL to 
probe cellular pH and demonstrate its application in 
whole blood. 
2. Materials and methods 
We have synthesized 2-fluoro-3,4-di(hydroxymethyl)-5-hydroxy-6- 
methyl-pyridine (6-Fluoropyridoxol or 6-FPOL) using Korytnyk’s 
method [15]. Briefly, this requires a three-step synthesis starting from 
pyridoxine hydrochloride. Diazotization of pyridoxine with benzene 
diazonium chloride yielded 6-phenazopyridoxol and dithionite reduc- 
tion produced 6-aminopyridoxol. In our experience the yield and purity 
of the product are significantly enhanced by careful repeated extraction 
at this stage from residual inorganic salts. 6-FPOL was then obtained 
using a modified Schiemann reaction [15]. NMR (‘H, 19F), IR, and 
melting point confirmed the identity and purity of 6-FPOL. 19F NMR 
experiments were performed using a 7 Tesla Oxford vertical bore mag- 
net (19F at 282.3 MHz) under control of a Techmag console. 19F chem- 
ical shift titration curves were established for 6-FPOL in distilled water 
and in the presence of dominant physiological ions (300 mM Na’, 300 
mM K’, 5 mM Mg2’, or 5 mM Ca2’), in blood plasma and at the 
temperatures 27,37 and 45°C. Sodium trifluoroacetate (TFA) was used 
as an external reference (0 ppm). 
Fresh whole blood was drawn from the lateral ear vein of New 
Zeeland White rabbits and stored chilled in the presence of heparin (up 
to 1 week) prior to NMR observation. Typically, l-12 mg 6-FPOL were 
dissolved in -500 ~1 water, plasma or whole rabbit blood for NMR 
studies. The pH of each sample was measured in the NMR tube using 
a combination pH electrode (Wilmad, Buena, NJ) attached to a pH 
meter (Corning 220, Sudbury, UK). Shimming was performed on the 
water signal and 19F NMR spectra were typically obtained in I min by 
averaging 16 transients with 2k data points across + 5000 Hz. Data were 
apodized with a 20 Hz exponential line broadening prior to Fourier 
transformation. “P NMR spectra were obtained at 12 1.5 MHz with 5 12 
transients and 4k data points across + 4000 Hz. In this case a 25 Hz line 
broadening was applied and methylenediphosphonic acid (MDPA) was 
used as an external reference. In some cases red blood cells and plasma 
were separated by mild centrifugation. 19F relaxation measurements 
were made using a traditional pulse-burst saturation recovery (TI) 
sequence [16]. In one case the blood was saturated with carbon monox- 
ide, to reduce line broadening associated with deoxyhemoglobin, and 
19F and “P NMR were performed at 37°C. 
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Fig. 1. Structure of 6-Fluoropyridoxol (6-FPOL) 
3. Results 
3.1. Titration 
6-FPOL exhibits a single sharp 19F NMR resonance 
in aqueous solution or plasma (line-width -20 Hz). 
19F NMR chemical shift of 6-FPOL is very sensitive to 
pH with a change of 9.76 ppm between acid and base 
(Fig. 2). From the titration curve in Fig. 3 coefficients of 
the Henderson-Hasselbach equation were determined as 
pK, = 8.2; G(acid) = -9.85 ppm; &base) = -19.61 ppm. 
The pH dependent 19F NMR chemical shift of 6-FPOL 
was essentially independent of the presence of metal ions 
(e.g. Na+, K’, Ca*‘, Mg*+) across the whole pH range 
(Fig. 3B). A similar titration curve was obtained in blood 
plasma. The titration curves were found to be independ- 
ent of temperature in the range 2745°C. 
3.2. Blood 
Adding 6-FPOL to whole blood produced two distinct 
well resolved 19F resonances immediately (Fig. 4a) at 
-10.72 + 0.03 ppm (I) and -11.34 + 0.06 ppm (E) corre- 
sponding respectively to pH 7.19 + 0.02 and 7.45 + 0.02. 
A signal-to-noise ratio of 5 was obtained for the larger 
upfield signal in a single acquisition using 4 mg of 
6-FPOL in 2 ml of blood (- 10 mM). The resonances were 
assigned respectively to intracellular (I) and extracellular 
(E) compartments as follows. 
(i) The separation of red blood cells from plasma by 
centrifugation produced a dominant 19F resonance (I) 
(Fig. 4b). Addition of saline to red blood cells resulted 
in increase of the second signal (E) (Fig. 4~). Separated 
plasma showed a single 19F signal (E) (Fig. 4d). 
(ii) The downfield peak had shorter spin-lattice relaxa- 
tion time: T,(I) -0.87 + 0.12 s, and T,(E) - 1.21 k 0.08 s. 
(iii) The pH electrode indicated an extra-cellular pH 
= 7.54 + 0.05 corresponding with the shift of the upfield 
signal. 
In a separate experiment using blood saturated with 
carbon monoxide to reduce intracellular paramagnetic 
line broadening from deoxyhemoglobin 3’P NMR indi- 
cated intra-cellular pH -7.14 ? 0.06 from the chemical 
shift difference of 2,3-DPG (diphosphoglycerate) 
(dS = 0.89 + 0.02 ppm) [17]. This corresponded with the 
downfield 19F resonance at 6 = -10.80 ppm (pH 7.23), 
whilst the upfield resonance (6 = -11.53, pH 7.52) corre- 
sponded with the electrode determination of pH 7.50. 
4. Discussion 
We have shown that 6-FPOL is a highly sensitive 
probe of pH and have exploited this molecule to measure 
both intra- and extracellular pH in whole blood. The pH 
dependent 19F NMR chemical shift of 6-FPOL is essen- 
tially independent of temperature, the presence of metal 
ions (e.g. K’, Mg*+) or plasma proteins and diffuses 
rapidly into red blood cells. 
NMR measurement of pH generally exploits the 
chemical shift titration of endogenous inorganic phos- 
phate (Pi) or phosphomonoesters. This is entirely non- 
Fig. 2. 282.3 MHz 19F NMR spectrum of 6-FPOL in acid and base (AS -9.78 ppm). CFICO,H as an external reference. 
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Fig. 3. (A) Plot of 19F chemical shift of 6-FPOL vs. pH in water at 37” C. 
pK, -8.2, G(acid) = -9.85 ppm, &base) = -19.61 ppm. (B) Influence of 
typical physiological metal ions or blood plasma on chemical shift. Plot 
of pH predicted from chemical shift in the presence of metal ions using 
Henderson-Hasselbach equation (+300 mM Na’, A 300 mM K+, 
o 5 mM Ca”, A 5 mM Mg*+, l whole plasma) vs. pH determined by 
electrode. 
invasive and is generally reported to provide pH esti- 
mates + 0.02 pH unit close to the pK, of 6.6 [5], but 
+ 0.3 may be more typical in vivo [l&19] .The pK, -6.6 
of Pi is ideally suited to monitor intracellular acidifica- 
tion, but is less suitable for basic compartments. In addi- 
tion, the pK, is sensitive to metals ions (e.g. [Mg2’]) and 
ionic strength and errors as great as 0.5 pH units have 
been estimated [6,17,20,21]. The chemical shift range of 
Pi is only 2.4 ppm and 3’P NMR spectra are often 
crowded with broad unresolved resonances and baseline 
distortion. In blood, Pi is often masked by 2,3 DPG 
[l&19,22]. 
Infusable pH-sensitive NMR probes may be designed 
with a specific pK, and resonances that do not overlap 
endogenous ignals. 19F is particularly attractive due its 
high detection sensitivity, large chemical shift (As> in 
response to minor alterations in pH and lack of back- 
ground signal. Deutsch et al. have pioneered this ap- 
proach [lo] and have successfully designed fluoromethyl 
alanine derivatives with a range of different pK, values 
[lo]. The first generation molecules were somewhat in- 
sensitive (d6 acid-base - 1 ppm) [ 10,23,24], but they have 
nonetheless been used in isolated cells [lo] and perfused 
organs [25,26]. Second generation molecules (fluoroanil- 
ines) have been described, but exhibited inappropriate 
PK, U31. 
6-FPOL has a large chemical shift range and pK, 
appropriate for certain physiological investigations, in 
particular in the basic range (pH > 6.5). This would com- 
plement studies of acidosis using Pi. The variation in 
chemical shift is smooth and monotonic indicating pro- 
tonation of a single group. 6-FPOL was originally re- 
ported in 1973 [15] and the titratability was exploited to 
probe the mechanism of glycogen phosphorylase activity 
[14]. The molecule does not appear to have been used to 
probe pH in vivo hitherto, although an acute toxicity 
> 100 mg/kg has been reported [15]. There is also some 
evidence for growth inhibition of tumor cells in vitro [ 151 
and we shall investigate possible cytotoxicity in the fu- 
ture. 
As discussed by others a pH probe should ideally meet 
several criteria: high NMR visibility, narrow lines, stabil- 
ity, no cytotoxicity, no physiological interference, cell 
penetration, fast exchange between acid and base forms, 
but slow exchange across cell membranes, large chemical 
shift range and pK, in the physiological range [ 10,181. We 
have now established that 6-FPOL penetrates and leaves 
red blood cells rapidly, but exchange is sufficiently slow 
to provide separate resonances for intra- and extracellu- 
lar compartments. Acid-base exchange is in the fast ex- 
change regime so that a single narrow line is observed for 
each compartment. 
Our pH measurements using 6-FPOL are independ- 
ently confirmed using pH electrodes (extracellular) and 
the 3’P NMR chemical shift differences of the resonances 
of 2,3 DPG (intracellular). The values also correspond 
with literature reports for blood derived with various 
techniques [17,27]. We are currently investigating the 
general utility of 6-FPOL to measure pH in a variety of 
cells and tissues and the possibility of targeting specific 
organs. 
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Fig. 4. 6-FPOL (10 mM) was added to whole blood with external TFA standard. The 19F NMR spectrum showed two distinct signals, which were 
assigned respectively to internal (I = -10.72 ppm; intracellular) and external (E = -11.34 ppm; plasma) compartments. (a) Whole blood; (b) red blood 
cells obtained by centrifugation of a; (c) saline added to (b); (d) plasma from (a). 
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